Alvimopan, a selective peripherally acting μ-opioid antagonist

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Alvimopan is a novel, peripherally acting μ-opioid antagonist that is being developed for the management of acute postoperative ileus and for the reversal of the delayed gastrointestinal and colonic transit that result in symptoms such as constipation, nausea and motility disorders in patients treated with opiate analgesics. There is a clinical need for effective medications for the treatment of postoperative ileus and opiate-induced constipation and other motility disorders. This review addresses the basic and applied pharmacology and current evidence for the use of the medication, alvimopan, in clinical gastroenterology.

Original languageEnglish (US)
Pages (from-to)157-165
Number of pages9
JournalNeurogastroenterology and Motility
Volume17
Issue number2
DOIs
StatePublished - Apr 2005

Fingerprint

alvimopan
Opiate Alkaloids
Narcotic Antagonists
Ileus
Constipation
Gastrointestinal Transit
Gastroenterology
Nausea
Analgesics
Pharmacology
Therapeutics

Keywords

  • Constipation
  • Gastrointestinal transit
  • Ileus
  • Irritable bowel

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology
  • Neuroscience(all)

Cite this

Alvimopan, a selective peripherally acting μ-opioid antagonist. / Camilleri, Michael.

In: Neurogastroenterology and Motility, Vol. 17, No. 2, 04.2005, p. 157-165.

Research output: Contribution to journalArticle

@article{7d4f1f7788ba4dd8a70aba3685f01d5b,
title = "Alvimopan, a selective peripherally acting μ-opioid antagonist",
abstract = "Alvimopan is a novel, peripherally acting μ-opioid antagonist that is being developed for the management of acute postoperative ileus and for the reversal of the delayed gastrointestinal and colonic transit that result in symptoms such as constipation, nausea and motility disorders in patients treated with opiate analgesics. There is a clinical need for effective medications for the treatment of postoperative ileus and opiate-induced constipation and other motility disorders. This review addresses the basic and applied pharmacology and current evidence for the use of the medication, alvimopan, in clinical gastroenterology.",
keywords = "Constipation, Gastrointestinal transit, Ileus, Irritable bowel",
author = "Michael Camilleri",
year = "2005",
month = "4",
doi = "10.1111/j.1365-2982.2005.00640.x",
language = "English (US)",
volume = "17",
pages = "157--165",
journal = "Neurogastroenterology and Motility",
issn = "1350-1925",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Alvimopan, a selective peripherally acting μ-opioid antagonist

AU - Camilleri, Michael

PY - 2005/4

Y1 - 2005/4

N2 - Alvimopan is a novel, peripherally acting μ-opioid antagonist that is being developed for the management of acute postoperative ileus and for the reversal of the delayed gastrointestinal and colonic transit that result in symptoms such as constipation, nausea and motility disorders in patients treated with opiate analgesics. There is a clinical need for effective medications for the treatment of postoperative ileus and opiate-induced constipation and other motility disorders. This review addresses the basic and applied pharmacology and current evidence for the use of the medication, alvimopan, in clinical gastroenterology.

AB - Alvimopan is a novel, peripherally acting μ-opioid antagonist that is being developed for the management of acute postoperative ileus and for the reversal of the delayed gastrointestinal and colonic transit that result in symptoms such as constipation, nausea and motility disorders in patients treated with opiate analgesics. There is a clinical need for effective medications for the treatment of postoperative ileus and opiate-induced constipation and other motility disorders. This review addresses the basic and applied pharmacology and current evidence for the use of the medication, alvimopan, in clinical gastroenterology.

KW - Constipation

KW - Gastrointestinal transit

KW - Ileus

KW - Irritable bowel

UR - http://www.scopus.com/inward/record.url?scp=16444366557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16444366557&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2982.2005.00640.x

DO - 10.1111/j.1365-2982.2005.00640.x

M3 - Article

C2 - 15787936

AN - SCOPUS:16444366557

VL - 17

SP - 157

EP - 165

JO - Neurogastroenterology and Motility

JF - Neurogastroenterology and Motility

SN - 1350-1925

IS - 2

ER -